Saturday 17 October 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%

Follow RVTY

Alert me

Market cap: $17.3B
P/E: 72.7×
Fwd P/E: 37.5×
Dividend yield: 0.23%
F-score: 6/9
Altman Z: 2.49
Beneish M: −2.45
Dividend safety: 80/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total sells 5.97

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	5	—	1	—	—	1	—	2	1

Insider Ownership 0.47%

Capital & Financial Ratios $m

Market Cap 17,260.00

Revenue 2,911.81

Net Income 237.55

Free Cash Flow 570.15

Net Debt 2,182.31

Current Ratio 1.80

Debt/Equity 0.44

P/E ratio 72.69

Fwd P/E 37.50

P/S ratio 5.85

P/B ratio 2.36

Past 5Y EPS Growth (20.43%)

This Y EPS Growth 5.86%

Next Y EPS Growth 10.00%

Next Y revenue growth (30.17%)

Next 5Y EPS Growth 8.51%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 92.48%

10-year low 10-year high

P/S against its own 10 years 95.76%

10-year low 10-year high

P/B against its own 10 years 35.79%

10-year low 10-year high

EV/Sales against its own 10 years 90.49%

10-year low 10-year high

EV/FCF against its own 10 years 62.79%

10-year low 10-year high

Dividends

Payout Ratio 0.17

Annual Dividend Rate 0.35

Annual Dividend Yield 0.23%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	0.20	0.07 0.07 0.07 0.07
2025	0.21	0.07 0.07 0.07 0.07
2024	0.28	0.07 0.07 0.07 0.07
2023	0.28	0.07 0.07 0.07 0.07
2022	0.28	0.07 0.07 0.07 0.07
2021	0.28	0.07 0.07 0.07 0.07
2020	0.28	0.07 0.07 0.07 0.07
2019	0.28	0.07 0.07 0.07 0.07
2018	0.28	0.07 0.07 0.07 0.07
2017	0.28	0.07 0.07 0.07 0.07
2016	0.28	0.07 0.07 0.07 0.07

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	1,603	1,163	920	1,023
Receivables	633	632	745	709
Inventory	428	368	379	379
Other	337	186	196	187
	3,001	2,350	2,240	2,298

	2023	2024	2025	Q'26
Payables	204	167	185	166
ST’ Debt	722	0	589	572
Other	—	—	—	—
	1,450	653	1,331	1,276

Compound Annual Growth %

	10y	5y	3y
Sales	3.10%	1.41%	(4.82%)
Cash Flow	7.34%	(8.16%)	(5.00%)
Earnings	1.28%	(19.82%)	(24.89%)
Book Value	13.14%	14.18%	(0.60%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	711	730	—	—	—
’25	665	720	699	772	2,856
’24	650	692	684	729	2,755
’23	675	709	671	696	2,751
’22	963	896	712	741	3,312
’21	1,308	1,228	861	430	3,828
’20	652	812	964	235	2,663

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	115	192	—	—	—
’25	128	134	139	182	583
’24	148	159	148	174	628
’23	63	(135)	(33)	197	91
’22	283	97	160	139	680
’21	474	288	314	336	1,411
’20	60	139	211	482	892

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	104	184	—	—	—
’25	112	115	120	162	509
’24	130	137	126	150	542
’23	43	(149)	(56)	172	10
’22	256	78	153	107	594
’21	459	267	291	307	1,325
’20	40	124	192	478	833

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.36	0.47	—	—	—
’25	0.35	0.46	0.40	0.87	2.07
’24	0.21	0.45	0.77	0.78	2.20
’23	4.50	0.28	0.08	0.64	5.55
’22	1.40	1.42	0.67	1.09	4.58
’21	3.37	2.19	1.11	1.41	7.99
’20	0.30	1.23	1.57	3.38	6.49

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	39.50	50.59	70.74	72.16	62.91	119.95	113.46	79.50	97.32	81.36	Analyst estimates 2026–2028 Powerpack
	High	57.28	74.12	98.33	103.00	149.95	203.16	201.05	145.35	129.50	128.29
People
People	Employees	8,000	11,000	12,500	13,000	14,000	16,700	16,700	11,500	11,000	11,000
	Revenue/emp, $m	0.26	0.21	0.22	0.22	0.19	0.23	0.20	0.24	0.25	0.26
Income, $m
Income, $m	Revenue	2,116	2,257	2,778	2,884	2,663	3,828	3,312	2,751	2,755	2,856
	Gross margin, %	47.95	47.57	48.27	48.41	64.97	63.59	60.08	55.98	55.81	54.77
	EBT	244	297	258	237	800	1,204	652	183	316	268
	EBT margin, %	11.54	13.15	9.28	8.22	30.04	31.44	19.68	6.65	11.47	9.39
	Net income	234	293	238	228	728	943	569	693	270	241
	Depreciation	103	114	203	239	207	352	480	439	434	410
Per share, $
Per share, $	Revenue	19.32	20.54	25.13	26.02	23.88	32.95	26.25	22.06	22.44	24.51
	Earnings	2.12	2.64	2.13	2.04	6.49	7.99	4.58	5.55	2.20	2.07
	Cash flow	3.20	2.63	2.81	3.28	8.00	12.14	5.39	0.73	5.12	5.00
	Capex	(0.10)	(0.35)	(0.50)	(0.73)	(0.53)	(0.74)	(0.68)	(0.65)	(0.71)	(0.63)
	Free cash flow	3.10	2.28	2.31	2.55	7.47	11.40	4.71	0.08	4.41	4.37
	Book value	19.67	22.79	23.38	25.39	33.50	61.48	58.52	63.13	62.46	62.21
	Shares, m	109	110	111	111	112	116	126	125	123	117
Valuation, ×
Valuation, ×	P/E	24.88	28.00	36.88	47.60	22.15	24.88	30.82	20.08	50.50	46.51
	P/S	2.74	3.60	3.13	3.73	6.01	6.10	5.38	5.01	4.97	3.95
	P/B	2.69	3.24	3.36	3.82	4.28	3.27	2.41	1.75	1.79	1.56
	EV/Sales	3.07	4.40	3.75	4.38	6.61	7.25	6.57	5.84	5.69	4.75
	EV/FCF	19.09	39.62	40.71	44.73	21.25	21.02	36.91	3,276.43	29.23	26.91
Cash, $m
Cash, $m	Operating cash flow	351	288	311	363	892	1,411	680	91	628	583
	Capex	(11)	(38)	(55)	(81)	(59)	(86)	(86)	(81)	(87)	(74)
	Free cash flow	340	250	256	283	833	1,325	594	10	542	509
Balance, $m
Balance, $m	Working capital	587	249	463	612	587	1,227	1,744	1,551	1,697	909
	Total debt	1,046	2,006	1,891	2,074	1,991	4,984	4,394	3,900	3,151	3,220
	Net debt	687	1,804	1,728	1,882	1,589	4,381	3,940	2,297	1,987	2,300
	Shareholders’ equity	2,154	2,503	2,585	2,814	3,735	7,141	7,383	7,873	7,667	7,250
Returns, %
Returns, %	ROA	5.55	5.64	3.94	3.64	10.04	8.22	3.91	5.01	2.08	1.96
	ROIC	6.48	4.29	4.69	4.82	10.18	6.83	4.10	1.85	2.24	2.33
	ROE	10.99	12.57	9.35	8.43	22.23	17.34	7.84	9.09	3.48	3.23

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
DGX Quest Diagnostics Incorporated	$26.4B	24.6×	20.8×	+10.21% (above 0%: growing)	+14.74% (above 0%: growing)	+5.28% (above 0%: growing)	33.75%	15.08%	Compare
LH Labcorp Holdings Inc.	$26.4B	26.2×	19.0×	+5.78% (above 0%: growing)	+28.42% (above 0%: growing)	−42.01% (below 0%: shrinking)	29.80%	12.10%	Compare
GH Guardant Health, Inc.	$22.3B	— (loss-making)	— (loss-making)	+44.33% (above 0%: growing)	n/m	−5.46% (below 0%: shrinking)	65.39%	(38.55%)	Compare
MEDP Medpace Holdings, Inc.	$17.6B	35.6×	26.7×	+17.24% (above 0%: growing)	+36.39% (above 0%: growing)	−3.03% (below 0%: shrinking)	71.36%	20.76%	Compare
RVTY Revvity Inc.	$17.3B	72.7×	37.5×	+1.31% (above 0%: growing)	+2.17% (above 0%: growing)	+59.29% (above 0%: growing)	57.13%	12.24%
CRL Charles River Laboratories International, Inc.	$14.6B	— (loss-making)	29.6×	−2.72% (below 0%: shrinking)	n/m	−12.22% (below 0%: shrinking)	36.19%	11.94%	Compare
ICLR ICON PLC	$13.5B	254×	23.8×	+1.20% (above 0%: growing)	−59.31% (below 0%: shrinking)	+109.66% (above 0%: growing)	23.23%	6.68%	Compare
QGEN QIAGEN N.V.	$9.5B	23.6×	17.5×	+0.28% (above 0%: growing)	+7.94% (above 0%: growing)	+30.45% (above 0%: growing)	63.62%	24.75%	Compare
TWST Twist Bioscience Corporation	$9.5B	— (loss-making)	— (loss-making)	+23.24% (above 0%: growing)	n/m	−7.23% (below 0%: shrinking)	52.76%	(30.65%)	Compare
Median of peers	$16.1B	26.2×	22.3×	+8.00%	+14.74%	−4.24%	44.48%	12.02%

All 52 Diagnostics & Research stocks →

Revvity Inc. (RVTY) key facts

Concern: Net income was $241.2 million, or $2.07 per share (basic), a net margin of 8.45%.
Strength: Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.
Revvity Inc. (RVTY) is a Diagnostics & Research company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, RVTY traded at $152.64, a market capitalization of $17.3 billion.
At that price the stock trades at 72.7× trailing-twelve-month earnings and 5.8× sales; its P/E is higher than 92% of its own readings over the past ten years.
Revvity Inc. pays an annual dividend of $0.35 per share, a yield of 0.23%, with a payout ratio of 16.7%.
Return on equity was 3.23% and debt-to-equity 0.44.
Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 2.49 (grey zone) for fiscal 2025.